Neisseria Gonorrhoeae Infections Treatment Market Report

Global and Region Neisseria Gonorrhoeae Infections Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：135
  • REPORT CODE：GMM975646
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Neisseria Gonorrhoeae Infections Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Neisseria Gonorrhoeae Infections Treatmentmarket, defines the market attractiveness level of Neisseria Gonorrhoeae Infections Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Neisseria Gonorrhoeae Infections Treatment industry, describes the types of Neisseria Gonorrhoeae Infections Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neisseria Gonorrhoeae Infections Treatment market and the development prospects and opportunities of Neisseria Gonorrhoeae Infections Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neisseria Gonorrhoeae Infections Treatment market in Chapter 13.

    By Player:

    • Sumitomo Dainippon Pharma Co, Ltd

    • Biolytics Pharma

    • Paratek Pharmaceuticals, Inc

    • GlaxoSmithKline Plc

    • Recce Pty Ltd

    • BioDiem Ltd

    • Allergan Plc

    • Redx Pharma Plc

    • Merck & Co, Inc

    • Debiopharm International SA

    • F Hoffmann-La Roche Ltd

    • Sarepta Therapeutics, Inc

    By Type:

    • Dalbavancin

    • Debio-1453

    • Gepotidacin Mesylate

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Neisseria Gonorrhoeae Infections Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Neisseria Gonorrhoeae Infections Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Neisseria Gonorrhoeae Infections Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Neisseria Gonorrhoeae Infections Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Neisseria Gonorrhoeae Infections Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Neisseria Gonorrhoeae Infections Treatment Consumption (2017-2022)

    • 7.2 United States Neisseria Gonorrhoeae Infections Treatment Consumption (2017-2022)

    • 7.3 Europe Neisseria Gonorrhoeae Infections Treatment Consumption (2017-2022)

    • 7.4 China Neisseria Gonorrhoeae Infections Treatment Consumption (2017-2022)

    • 7.5 Japan Neisseria Gonorrhoeae Infections Treatment Consumption (2017-2022)

    • 7.6 India Neisseria Gonorrhoeae Infections Treatment Consumption (2017-2022)

    • 7.7 South Korea Neisseria Gonorrhoeae Infections Treatment Consumption (2017-2022)

    8 Region and Country-wise Neisseria Gonorrhoeae Infections Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Neisseria Gonorrhoeae Infections Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Neisseria Gonorrhoeae Infections Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Neisseria Gonorrhoeae Infections Treatment Consumption Forecast (2022-2028)

    • 8.4 China Neisseria Gonorrhoeae Infections Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Neisseria Gonorrhoeae Infections Treatment Consumption Forecast (2022-2028)

    • 8.6 India Neisseria Gonorrhoeae Infections Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Neisseria Gonorrhoeae Infections Treatment Consumption Forecast (2022-2028)

    9 Global Neisseria Gonorrhoeae Infections Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Neisseria Gonorrhoeae Infections Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Dalbavancin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Debio-1453 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Gepotidacin Mesylate Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Neisseria Gonorrhoeae Infections Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Neisseria Gonorrhoeae Infections Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Neisseria Gonorrhoeae Infections Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Dalbavancin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Debio-1453 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Gepotidacin Mesylate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Neisseria Gonorrhoeae Infections Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Neisseria Gonorrhoeae Infections Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Neisseria Gonorrhoeae Infections Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Neisseria Gonorrhoeae Infections Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Neisseria Gonorrhoeae Infections Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Neisseria Gonorrhoeae Infections Treatment Market Competitive Analysis

    • 14.1 Sumitomo Dainippon Pharma Co, Ltd

      • 14.1.1 Sumitomo Dainippon Pharma Co, Ltd Company Details

      • 14.1.2 Sumitomo Dainippon Pharma Co, Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sumitomo Dainippon Pharma Co, Ltd Neisseria Gonorrhoeae Infections Treatment Product and Service

    • 14.2 Biolytics Pharma

      • 14.2.1 Biolytics Pharma Company Details

      • 14.2.2 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Product and Service

    • 14.3 Paratek Pharmaceuticals, Inc

      • 14.3.1 Paratek Pharmaceuticals, Inc Company Details

      • 14.3.2 Paratek Pharmaceuticals, Inc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Paratek Pharmaceuticals, Inc Neisseria Gonorrhoeae Infections Treatment Product and Service

    • 14.4 GlaxoSmithKline Plc

      • 14.4.1 GlaxoSmithKline Plc Company Details

      • 14.4.2 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Product and Service

    • 14.5 Recce Pty Ltd

      • 14.5.1 Recce Pty Ltd Company Details

      • 14.5.2 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Product and Service

    • 14.6 BioDiem Ltd

      • 14.6.1 BioDiem Ltd Company Details

      • 14.6.2 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Product and Service

    • 14.7 Allergan Plc

      • 14.7.1 Allergan Plc Company Details

      • 14.7.2 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Product and Service

    • 14.8 Redx Pharma Plc

      • 14.8.1 Redx Pharma Plc Company Details

      • 14.8.2 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Product and Service

    • 14.9 Merck & Co, Inc

      • 14.9.1 Merck & Co, Inc Company Details

      • 14.9.2 Merck & Co, Inc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merck & Co, Inc Neisseria Gonorrhoeae Infections Treatment Product and Service

    • 14.10 Debiopharm International SA

      • 14.10.1 Debiopharm International SA Company Details

      • 14.10.2 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Product and Service

    • 14.11 F Hoffmann-La Roche Ltd

      • 14.11.1 F Hoffmann-La Roche Ltd Company Details

      • 14.11.2 F Hoffmann-La Roche Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 F Hoffmann-La Roche Ltd Neisseria Gonorrhoeae Infections Treatment Product and Service

    • 14.12 Sarepta Therapeutics, Inc

      • 14.12.1 Sarepta Therapeutics, Inc Company Details

      • 14.12.2 Sarepta Therapeutics, Inc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Sarepta Therapeutics, Inc Neisseria Gonorrhoeae Infections Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Neisseria Gonorrhoeae Infections Treatment

    • Figure Neisseria Gonorrhoeae Infections Treatment Picture

    • Table Global Neisseria Gonorrhoeae Infections Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neisseria Gonorrhoeae Infections Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neisseria Gonorrhoeae Infections Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Neisseria Gonorrhoeae Infections Treatment Consumption by Country (2017-2022)

    • Figure United States Neisseria Gonorrhoeae Infections Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Neisseria Gonorrhoeae Infections Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Neisseria Gonorrhoeae Infections Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Neisseria Gonorrhoeae Infections Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Neisseria Gonorrhoeae Infections Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Neisseria Gonorrhoeae Infections Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Neisseria Gonorrhoeae Infections Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Neisseria Gonorrhoeae Infections Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Neisseria Gonorrhoeae Infections Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Neisseria Gonorrhoeae Infections Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Neisseria Gonorrhoeae Infections Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Neisseria Gonorrhoeae Infections Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Neisseria Gonorrhoeae Infections Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dalbavancin Consumption and Growth Rate (2017-2022)

    • Figure Global Debio-1453 Consumption and Growth Rate (2017-2022)

    • Figure Global Gepotidacin Mesylate Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Dalbavancin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Debio-1453 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gepotidacin Mesylate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Neisseria Gonorrhoeae Infections Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Neisseria Gonorrhoeae Infections Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Sumitomo Dainippon Pharma Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table Sumitomo Dainippon Pharma Co, Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sumitomo Dainippon Pharma Co, Ltd Neisseria Gonorrhoeae Infections Treatment Product and Service

    • Table Biolytics Pharma (Foundation Year, Company Profile and etc.)

    • Table Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Product and Service

    • Table Paratek Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Paratek Pharmaceuticals, Inc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Paratek Pharmaceuticals, Inc Neisseria Gonorrhoeae Infections Treatment Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Product and Service

    • Table Recce Pty Ltd (Foundation Year, Company Profile and etc.)

    • Table Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Product and Service

    • Table BioDiem Ltd (Foundation Year, Company Profile and etc.)

    • Table BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Product and Service

    • Table Allergan Plc (Foundation Year, Company Profile and etc.)

    • Table Allergan Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Plc Neisseria Gonorrhoeae Infections Treatment Product and Service

    • Table Redx Pharma Plc (Foundation Year, Company Profile and etc.)

    • Table Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Neisseria Gonorrhoeae Infections Treatment Product and Service

    • Table Debiopharm International SA (Foundation Year, Company Profile and etc.)

    • Table Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Neisseria Gonorrhoeae Infections Treatment Product and Service

    • Table Sarepta Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Sarepta Therapeutics, Inc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sarepta Therapeutics, Inc Neisseria Gonorrhoeae Infections Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US